Webinar | September 3, 2024

Straightforward AAV Manufacturing Process Scale Up From Bench-Xcale To 2000L STR

Source: Polyplus

In this webinar, one of the key challenges in delivering AAV-based therapies to patients, efficiently scaling bench-scale processes to commercial GMP manufacturing while meeting the demanding dosage requirements, is achieved. Experts from Polyplus, Exothera, and Alexion united to develop a highly scalable AAV manufacturing platform, capable of supporting volumes from 1L to 200L and up to 2000L.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Polyplus